# OnCo record h3c2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/h3c2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "h3c2" ;
  schema:name "H3C2"@en ;
  schema:alternateName "H3 clustered histone 2"@en, "Histone H3.1"@en, "H3/l"@en, "H3FL"@en, "HIST1H3B"@en, "H3C2" ;
  schema:description "H3C2 (Histone H3.1) is a gene that drives cell growth when it is altered. The public catalogues list it as an oncogene driver, a tumour suppressor and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Breast cancer, Bladder & urothelial cancer, Oesophageal cancer and 5 more."@en ;
  schema:url <https://onco.cc/targets/h3c2/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4776>, <https://www.uniprot.org/uniprotkb/P68431/entry>, <https://www.ncbi.nlm.nih.gov/gene/8358>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000286522> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "oncogene" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4776>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000286522>, <https://www.uniprot.org/uniprotkb/P68431/entry>, <https://www.ncbi.nlm.nih.gov/gene/8358> ;
  onco:related <https://onco.cc/collections/civic/>, <https://onco.cc/collections/open-targets/>, <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dipg-dmg/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/oesophageal-adenocarcinoma/> .